Pharmaceutical company in
Horgen

Jantar GmbH

Since 2015 · 1–10 empl.

The core activity of Jantar GmbH is the development of pharmaceutical products, particularly research and development (R&D) of medications for the treatment of rhinosinusitis, specifically with the active ingredient JT-1 for nasal spray application.

Numab Therapeutics AG

Since 2016 · 51–100 empl.

Numab Therapeutics AG is a biotechnology company developing multispecific antibody therapeutics. Its proprietary platform and pipeline focus on therapies for immunological and inflammatory diseases and cancer.

CDR-Life AG

Since 2017 · 51–100 empl.

The company develops and commercializes new medicines, particularly T-cell activated cancer medicines, and provides services in the areas of research and development, clinical trials, pharmacology, toxicology and analytics.

Dimericon Therapeutics AG

Since 2021 · 11–20 empl.

Dimericon Therapeutics AG is listed as a member of the Swiss Biotech Association on the Swiss Biotech platform and is identified there as a private company. The publicly available listing does not provide details on products, services, or research focus.

PharmaBlock Sciences (Switzerland) AG

Since 2024 · 1–10 empl.

PharmaBlock Sciences (Switzerland) AG is part of the PharmaBlock group, which provides chemistry products and services for pharmaceutical research, development and commercial manufacturing. Its activities include supplying building blocks, chemistry research, and development and manufacturing services for drug substances, intermediates and dosage forms.

SwissQpro GmbH

Since 2015 · 1–10 empl.

SwissQpro GmbH distributes cosmetics made in Switzerland. Its range includes products from the La Vallée, Yves Swiss and Mettler 1929 brands, which it distributes internationally.

Synergy biosurgical AG

Since 2007 · 1–10 empl.

Patrick Bobbitt Pharmaceutical and Biotechnology Consulting

Since 2016 · 1–10 empl.